Trial-related deaths
medical studies in India

Trial-related deaths in poor countries

BAYER is carrying out an ever increasing number of dangerous drug trials in poor countries, because they offer a large reservoir of test subjects, low prices, fast procedures and little supervision by the authorities. In India alone, there have been at least 138 fatalities as a result of BAYER's drug trials on humans in the last four years. The Board of Management bears responsibility for this.

=> April 2013: Countermotion to Bayer Shareholder Meeting

=> Xarelto: BAYER pays compensation in China

=> July 2012: Novartis, Bayer named in Indian trial death list

=> Open letter to the BAYER board

=> Coalition introduces Countermotion to Bayer Shareholder Meeting

=> Lancet: Regulation failing to keep up with India’s trials boom

=> The clinical trial scenario in India

=> The Independent: How drugs companies exploit Indian 'guinea pigs'

=> MSNBC: In India, oversight lacking in outsourced drug trials